MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act. COVID relief and pandemic response, pandemic preparedness,; Supply chain, global operations, trade,; Pharmacy provider status, retail pharmacy H.R.2759 and S.1362,;ARPA-H, clinical trials, healthcare innovation, CURES 2.0,; Social determinants of health, health disparities in underserved communities; chronic health conditions H.R.2503.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| DAMON SHELBY PORTER | — |
| PETER SLONE | — |
Medicare/Medicaid MMM
General Medicare/Medicaid Issues,; Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response. Drug pricing and transparency, access and adherence H.R.3 and H.R.19,; The Improving Seniors' Timely Access to Care Act H.R.3173,; Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.1909 and H.R.3554,;The Safe Step Act H.R.2163 and S.464.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| THOMAS BORCK | — |
| BEN JONES | — |
| LISA LANGENDERFER | — |
| DAMON SHELBY PORTER | — |
| PETER SLONE New | — |
Pharmacy PHA
Pharmacy provider status, retail pharmacy H.R.2759 and S.1362,; Pharmacy DIR Reform to Reduce Senior Drug Costs Act S.1909 and H.R.3554,; Drug pricing and transparency, access and adherence H.R.3 and H.R.19
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| THOMAS BORCK | — |
| BEN JONES | — |
| LISA LANGENDERFER | — |
| DAMON SHELBY PORTER | — |
Taxation/Internal Revenue Code TAX
Drug pricing and transparency, access and adherence H.R.3 and H.R.19.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| DAMON SHELBY PORTER | — |
Tariff (miscellaneous tariff bills) TAR
Social determinants of health; health disparities in underserved communities; chronic health conditions H.R.2503,; Drug pricing and transparency, access and adherence,; Domestic sourcing and production,; COVID relief and pandemic response, pandemic preparedness; Supply chain, global operations, trade.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA C BABB | — |
| DAMON SHELBY PORTER | — |
| PETER SLONE New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.